Dr Reddys Laboratories Stock Price - RDY

53.04
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
53.04
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Dr Reddys Laboratories Ltd RDY NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.07 0.13% 53.04 53.02 53.88 53.35 52.97 20:00:00
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,009 134,496 $ 53.54 $ 7,200,307 219,007 33.33 - 53.88
Last Trade Time Type Quantity Stock Price Currency
18:30:00 18,340 $ 53.04 USD

Dr Reddys Laboratories Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 8.79B 165.77M 165.77M $ 2.32B $ 260.97M 1.56 32.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.52M $ - 53.21% - -

more financials information »

Dr Reddys Laboratories News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RDY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week53.0053.8851.8352.98234,1320.040.08%
1 Month53.6453.8848.56551.31234,841-0.60-1.12%
3 Months38.9753.8833.3346.86253,11614.0736.1%
6 Months40.3853.8833.3344.87218,06012.6631.35%
1 Year39.5253.8833.3341.69198,30113.5234.21%
3 Years39.3653.8828.1336.65258,50013.6834.76%
5 Years53.7468.0028.1342.35286,168-0.70-1.3%

Dr Reddys Laboratories Description

With headquarters in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceuticals. The firm operates in three divisions: global generics, pharmaceutical services and active ingredients, and proprietary products and other, which make up most of the company's revenue at about 80%, 15%, and 3%, respectively. Most of the company's sales are based in the United States.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.